{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:46:37Z","timestamp":1792622797625,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873851"],"award-info":[{"award-number":["81873851"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although some studies have indicated that Psoriasis could contribute to the risk of idiopathic pulmonary fibrosis (IPF), no study has reported a clear causal association between them. Our aim was to explore the potential relationship between Psoriasis and IPF using Mendelian randomization (MR) design.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To explore a causal association between Psoriasis and IPF, we used genetic instruments from the largest available genome-wide association study (GWAS) of European ancestry, including psoriasis (5314 cases, 457,619 controls) and IPF (1028 cases, 196,986 controls). Our main analyses were conducted by inverse-variance weighted (IVW) method with random-effects model, with the other complementary four analyses: weighted median method, weighted mode, multivariable MR and MR-Egger approach.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results of IVW methods demonstrated that genetically predicted psoriasis was significantly associated with higher odds of IPF, with an odds ratio (OR) of 1.09 (95%CI, 1.01\u20131.18; P\u2009=\u20090.02). Weighted median method, weighted mode and multivariable MR also demonstrated directionally similar results (P\u2009&lt;\u20090.05), while the MR-Egger regression did not reveal the impact of psoriasis on IPF (OR\u2009=\u20091.09, 95%CI, 0.98\u20131.21; P\u2009=\u20090.11). In addition, both funnel plots and MR-Egger intercepts indicated no directional pleiotropic effects between psoriasis and IPF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study provided potential evidence between genetically predicted psoriasis and IPF, which suggests that understanding the mutual risk factors between psoriasis and IPF can facilitate the clinical management of both diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-024-02721-5","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T02:02:09Z","timestamp":1708912929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Psoriasis may increase the risk of idiopathic pulmonary fibrosis: a two-sample Mendelian randomization study"],"prefix":"10.1186","volume":"25","author":[{"given":"Lingli","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yile","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"2721_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369: m1590.","journal-title":"BMJ"},{"key":"2721_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397:1301\u201315.","journal-title":"Lancet"},{"key":"2721_CR3","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1038\/s41467-023-39020-4","volume":"14","author":"F Ma","year":"2023","unstructured":"Ma F, Plazyo O, Billi AC, Tsoi LC, Xing X, Wasikowski R, Gharaee-Kermani M, Hile G, Jiang Y, Harms PW, et al. Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis. Nat Commun. 2023;14:3455.","journal-title":"Nat Commun"},{"key":"2721_CR4","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1038\/s41467-019-12253-y","volume":"10","author":"N Fyhrquist","year":"2019","unstructured":"Fyhrquist N, Muirhead G, Prast-Nielsen S, Jeanmougin M, Olah P, Skoog T, Jules-Clement G, Feld M, Barrientos-Somarribas M, Sinkko H, et al. Microbe-host interplay in atopic dermatitis and psoriasis. Nat Commun. 2019;10:4703.","journal-title":"Nat Commun"},{"key":"2721_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263\u201371.","journal-title":"Lancet"},{"key":"2721_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76:377\u201390.","journal-title":"J Am Acad Dermatol"},{"key":"2721_CR7","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/jid.2015.87","volume":"135","author":"R Parisi","year":"2015","unstructured":"Parisi R, Rutter MK, Lunt M, Young HS, Symmons DPM, Griffiths CEM, Ashcroft DM. Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol. 2015;135:2189\u201397.","journal-title":"J Invest Dermatol"},{"key":"2721_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/ecco-jcc\/jjz152","volume":"14","author":"F Alinaghi","year":"2020","unstructured":"Alinaghi F, Tekin HG, Burisch J, Wu JJ, Thyssen JP, Egeberg A. Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease-a systematic review and meta-analysis. J Crohns Colitis. 2020;14:351\u201360.","journal-title":"J Crohns Colitis"},{"key":"2721_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145221","volume":"10","author":"X Li","year":"2015","unstructured":"Li X, Kong L, Li F, Chen C, Xu R, Wang H, Peng S, Zhou M, Li B. Association between psoriasis and chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS ONE. 2015;10: e0145221.","journal-title":"PLoS ONE"},{"key":"2721_CR10","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1111\/bjd.13772","volume":"172","author":"N Ballardini","year":"2015","unstructured":"Ballardini N. The association between psoriasis and asthma. Br J Dermatol. 2015;172:1485\u20136.","journal-title":"Br J Dermatol"},{"key":"2721_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jaad.2012.04.039","volume":"67","author":"JJ Wu","year":"2012","unstructured":"Wu JJ, Nguyen TU, Poon KY, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012;67:924\u201330.","journal-title":"J Am Acad Dermatol"},{"key":"2721_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jaad.2009.02.015","volume":"61","author":"M Makredes","year":"2009","unstructured":"Makredes M, Robinson D Jr, Bala M, Kimball AB. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J Am Acad Dermatol. 2009;61:405\u201310.","journal-title":"J Am Acad Dermatol"},{"key":"2721_CR13","doi-asserted-by":"publisher","first-page":"5919304","DOI":"10.1155\/2019\/5919304","volume":"2019","author":"G Ishikawa","year":"2019","unstructured":"Ishikawa G, Dua S, Mathur A, Acquah SO, Salvatore M, Beasley MB, Padilla ML. Concomitant interstitial lung disease with psoriasis. Can Respir J. 2019;2019:5919304.","journal-title":"Can Respir J"},{"key":"2721_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5858\/arpa.2021-0616-OA","volume":"147","author":"YM Butt","year":"2022","unstructured":"Butt YM, Smith ML, Tazelaar HD, Roden AC, Mengoli MC, Larsen BT. Surgical pathology of diffuse parenchymal lung disease in patients with psoriasis or psoriatic arthritis. Arch Pathol Lab Med. 2022;147:525\u201333.","journal-title":"Arch Pathol Lab Med"},{"key":"2721_CR15","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1111\/1346-8138.16084","volume":"48","author":"Y Okubo","year":"2021","unstructured":"Okubo Y, Kotowsky N, Gao R, Saito K, Morita A. Clinical characteristics and health-care resource utilization in patients with generalized pustular psoriasis using real-world evidence from the Japanese Medical Data Center database. J Dermatol. 2021;48:1675\u201387.","journal-title":"J Dermatol"},{"key":"2721_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107798","volume":"222","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, Maher TM, Tzouvelekis A, Ryerson CJ. Idiopathic pulmonary fibrosis: disease mechanisms and drug development. Pharmacol Ther. 2021;222: 107798.","journal-title":"Pharmacol Ther"},{"key":"2721_CR17","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389:1941\u201352.","journal-title":"Lancet"},{"key":"2721_CR18","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1164\/rccm.201809-1650OC","volume":"199","author":"DN O\u2019Dwyer","year":"2019","unstructured":"O\u2019Dwyer DN, Ashley SL, Gurczynski SJ, Xia M, Wilke C, Falkowski NR, Norman KC, Arnold KB, Huffnagle GB, Salisbury ML, et al. Lung microbiota contribute to pulmonary inflammation and disease progression in pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199:1127\u201338.","journal-title":"Am J Respir Crit Care Med"},{"key":"2721_CR19","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3390\/ijms23031767","volume":"23","author":"M Mleczko","year":"2022","unstructured":"Mleczko M, Gerkowicz A, Krasowska D. Chronic inflammation as the underlying mechanism of the development of lung diseases in psoriasis: a systematic review. Int J Mol Sci. 2022;23:1767.","journal-title":"Int J Mol Sci"},{"key":"2721_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12866-021-02125-1","volume":"21","author":"X Zhang","year":"2021","unstructured":"Zhang X, Shi L, Sun T, Guo K, Geng S. Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients. BMC Microbiol. 2021;21:78.","journal-title":"BMC Microbiol"},{"key":"2721_CR21","first-page":"1248","volume":"12","author":"R Gupta","year":"2015","unstructured":"Gupta R, Espiritu J. Azathioprine for the rare case of nonspecific interstitial pneumonitis in a patient with psoriasis. Ann Am Thorac Soc. 2015;12:1248\u201351.","journal-title":"Ann Am Thorac Soc"},{"key":"2721_CR22","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/ced.14259","volume":"45","author":"Y Matsumoto","year":"2020","unstructured":"Matsumoto Y, Abe N, Tobita R, Kawakami H, Nakayama H, Setoguchi Y, Tsuboi R, Okubo Y. The risk of interstitial lung disease during biological treatment in Japanese patients with psoriasis. Clin Exp Dermatol. 2020;45:853\u20138.","journal-title":"Clin Exp Dermatol"},{"key":"2721_CR23","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318:1925\u20136.","journal-title":"JAMA"},{"key":"2721_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362: k601.","journal-title":"BMJ"},{"key":"2721_CR25","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ije\/dyy258","volume":"48","author":"J Bowden","year":"2018","unstructured":"Bowden J, Del Greco MF, Minelli C, Zhao Q, Lawlor DA, Sheehan NA, Thompson J, Davey Smith G. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol. 2018;48:728\u201342.","journal-title":"Int J Epidemiol"},{"key":"2721_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","volume":"28","author":"S Burgess","year":"2017","unstructured":"Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017;28:30\u201342.","journal-title":"Epidemiology"},{"key":"2721_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u201325.","journal-title":"Int J Epidemiol"},{"key":"2721_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mayocpiqo.2018.07.006","volume":"2","author":"H Kawamoto","year":"2018","unstructured":"Kawamoto H, Hara H, Minagawa S, Numata T, Araya J, Kaneko Y, Umezawa Y, Asahina A, Nakagawa H, Kuwano K. Interstitial pneumonia in psoriasis. Mayo Clin Proc Innov Qual Outcomes. 2018;2:370\u20137.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"2721_CR29","volume":"14","author":"P Kharibam","year":"2022","unstructured":"Kharibam P, Laishram S, Choudhary N, Choudhury A, Kant R. Concomitant interstitial lung disease with psoriasis. Cureus. 2022;14: e26979.","journal-title":"Cureus"},{"key":"2721_CR30","first-page":"21","volume":"9","author":"YJ Nie","year":"2022","unstructured":"Nie YJ, Wu SH, Xuan YH, Yan G. Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis. Mil Med Res. 2022;9:21.","journal-title":"Mil Med Res"},{"key":"2721_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.623430","volume":"12","author":"E Fraser","year":"2021","unstructured":"Fraser E, Denney L, Antanaviciute A, Blirando K, Vuppusetty C, Zheng Y, Repapi E, Iotchkova V, Taylor S, Ashley N, et al. Multi-modal characterization of monocytes in idiopathic pulmonary fibrosis reveals a primed type I interferon immune phenotype. Front Immunol. 2021;12: 623430.","journal-title":"Front Immunol"},{"key":"2721_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1465-9921-4-6","volume":"4","author":"P Latsi","year":"2003","unstructured":"Latsi P, Pantelidis P, Vassilakis D, Sato H, Welsh KI, du Bois RM. Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in Idiopathic Pulmonary Fibrosis. Respir Res. 2003;4:6.","journal-title":"Respir Res"},{"key":"2721_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jlb.59.4.505","volume":"59","author":"G Trinchieri","year":"1996","unstructured":"Trinchieri G, Gerosa F. Immunoregulation by interleukin-12. J Leukoc Biol. 1996;59:505\u201311.","journal-title":"J Leukoc Biol"},{"key":"2721_CR34","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.rmed.2005.06.016","volume":"100","author":"PG Tsoutsou","year":"2006","unstructured":"Tsoutsou PG, Gourgoulianis KI, Petinaki E, Germenis A, Tsoutsou AG, Mpaka M, Efremidou S, Molyvdas PA. Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis. Respir Med. 2006;100:938\u201345.","journal-title":"Respir Med"},{"key":"2721_CR35","doi-asserted-by":"publisher","first-page":"8120","DOI":"10.1038\/s41467-023-43336-6","volume":"14","author":"N Otaki","year":"2023","unstructured":"Otaki N, Motomura Y, Terooatea T, Thomas Kelly S, Mochizuki M, Takeno N, Koyasu S, Tamamitsu M, Sugihara F, Kikuta J, et al. Activation of ILC2s through constitutive IFN\u03b3 signaling reduction leads to spontaneous pulmonary fibrosis. Nat Commun. 2023;14:8120.","journal-title":"Nat Commun"},{"key":"2721_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.yjmcc.2018.07.003","volume":"121","author":"NA Das","year":"2018","unstructured":"Das NA, Carpenter AJ, Yoshida T, Kumar SA, Gautam S, Mostany R, Izadpanah R, Kumar A, Mummidi S, Siebenlist U, Chandrasekar B. TRAF3IP2 mediates TWEAK\/TWEAKR-induced pro-fibrotic responses in cultured cardiac fibroblasts and the heart. J Mol Cell Cardiol. 2018;121:107\u201323.","journal-title":"J Mol Cell Cardiol"},{"key":"2721_CR37","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1038\/s41467-022-33767-y","volume":"13","author":"W Wang","year":"2022","unstructured":"Wang W, Bale S, Wei J, Yalavarthi B, Bhattacharyya D, Yan JJ, Abdala-Valencia H, Xu D, Sun H, Marangoni RG, et al. Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs. Nat Commun. 2022;13:6358.","journal-title":"Nat Commun"},{"key":"2721_CR38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41423-020-00602-7","volume":"18","author":"K Onomoto","year":"2021","unstructured":"Onomoto K, Onoguchi K, Yoneyama M. Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors. Cell Mol Immunol. 2021;18:539\u201355.","journal-title":"Cell Mol Immunol"},{"key":"2721_CR39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.15252\/emmm.201607027","volume":"9","author":"H Zhu","year":"2017","unstructured":"Zhu H, Lou F, Yin Q, Gao Y, Sun Y, Bai J, Xu Z, Liu Z, Cai W, Ke F, et al. RIG-I antiviral signaling drives interleukin-23 production and psoriasis-like skin disease. EMBO Mol Med. 2017;9:589\u2013604.","journal-title":"EMBO Mol Med"},{"key":"2721_CR40","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.chest.2019.10.032","volume":"157","author":"G Sheng","year":"2020","unstructured":"Sheng G, Chen P, Wei Y, Yue H, Chu J, Zhao J, Wang Y, Zhang W, Zhang HL. Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta-analysis. Chest. 2020;157:1175\u201387.","journal-title":"Chest"},{"key":"2721_CR41","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1183\/09031936.97.10092040","volume":"10","author":"M Yonemaru","year":"1997","unstructured":"Yonemaru M, Kasuga I, Kusumoto H, Kunisawa A, Kiyokawa H, Kuwabara S, Ichinose Y, Toyama K. Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. Eur Respir J. 1997;10:2040\u20135.","journal-title":"Eur Respir J"},{"key":"2721_CR42","doi-asserted-by":"publisher","first-page":"8973","DOI":"10.1021\/acs.jmedchem.9b00444","volume":"62","author":"ST Wrobleski","year":"2019","unstructured":"Wrobleski ST, Moslin R, Lin S, Zhang Y, Spergel S, Kempson J, Tokarski JS, Strnad J, Zupa-Fernandez A, Cheng L, et al. Highly selective inhibition of tyrosine kinase 2 (TYK2) for the treatment of autoimmune diseases: discovery of the allosteric inhibitor BMS-986165. J Med Chem. 2019;62:8973\u201395.","journal-title":"J Med Chem"},{"key":"2721_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrrheum.2015.167","volume":"12","author":"DM Schwartz","year":"2016","unstructured":"Schwartz DM, Bonelli M, Gadina M, O\u2019Shea JJ. Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases. Nat Rev Rheumatol. 2016;12:25\u201336.","journal-title":"Nat Rev Rheumatol"},{"key":"2721_CR44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40265-020-01261-8","volume":"80","author":"M Nogueira","year":"2020","unstructured":"Nogueira M, Puig L, Torres T. JAK inhibitors for treatment of psoriasis: focus on selective TYK2 inhibitors. Drugs. 2020;80:341\u201352.","journal-title":"Drugs"},{"key":"2721_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104488","volume":"89","author":"S Yuan","year":"2023","unstructured":"Yuan S, Wang L, Zhang H, Xu F, Zhou X, Yu L, Sun J, Chen J, Ying H, Xu X, et al. Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases. EBioMedicine. 2023;89: 104488.","journal-title":"EBioMedicine"},{"key":"2721_CR46","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.chest.2022.07.027","volume":"163","author":"OC Leavy","year":"2023","unstructured":"Leavy OC, Allen RJ, Kraven LM, Morgan AD, Tobin MD, Quint JK, Jenkins RG, Wain LV. The use of genetic information to define idiopathic pulmonary fibrosis in UK biobank. Chest. 2023;163:362\u20135.","journal-title":"Chest"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02721-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-024-02721-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-024-02721-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T22:10:20Z","timestamp":1709244620000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-024-02721-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2721"],"URL":"https:\/\/doi.org\/10.1186\/s12931-024-02721-5","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"assertion":[{"value":"11 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}